AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Trading Down 0.6% – Time to Sell?

Posted by ABMN Staff on Feb 24th, 2026

Shares of AdvisorShares Psychedelics ETF (NYSEARCA:PSIL – Get Free Report) dropped 0.6% during trading on Monday . The company traded as low as $16.80 and last traded at $17.03. Approximately 18,499 shares changed hands during mid-day trading, a decline of 10% from the average daily volume of 20,591 shares. The stock had previously closed at $17.14.

AdvisorShares Psychedelics ETF Stock Down 0.6%

The stock’s 50 day simple moving average is $17.25 and its two-hundred day simple moving average is $17.98.

AdvisorShares Psychedelics ETF Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 29th. Investors of record on Monday, December 22nd were given a dividend of $1.6839 per share. The ex-dividend date was Monday, December 22nd. This is a positive change from AdvisorShares Psychedelics ETF’s previous quarterly dividend of $0.02. This represents a $6.74 dividend on an annualized basis and a yield of 39.6%.

Institutional Trading of AdvisorShares Psychedelics ETF

A hedge fund recently bought a new stake in AdvisorShares Psychedelics ETF stock. CIBC Bancorp USA Inc. bought a new position in AdvisorShares Psychedelics ETF (NYSEARCA:PSIL – Free Report) in the third quarter, according to its most recent disclosure with the SEC. The firm bought 25,019 shares of the company’s stock, valued at approximately $475,000. CIBC Bancorp USA Inc. owned about 2.50% of AdvisorShares Psychedelics ETF as of its most recent SEC filing.

AdvisorShares Psychedelics ETF Company Profile

(Get Free Report)

The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.